Proton Pump Inhibitor Co-medication Reduces Mycophenolate Acid Drug Exposure in Heart Transplant Recipients

This publication has 35 references indexed in Scilit:

• Defining Algorithms for Efficient Therapeutic Drug Monitoring of Mycophenolate Mofetil in Heart Transplant Recipients
  Therapeutic Drug Monitoring, 2008
• Effect of CYP2C19 *2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians
  British Journal of Clinical Pharmacology, 2008
• Effects of gastric emptying on oral mycophenolic acid pharmacokinetics in stable renal allograft recipients
  British Journal of Clinical Pharmacology, 2007
• Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant Recipients
  Clinical Pharmacokinetics, 2007
• Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors
  Drug Safety, 2006
• Immunosuppressive Therapy for Paediatric Transplant Patients
  Clinical Pharmacokinetics, 2002
• Mycophenolic Acid Area under the Curve Values in African American and Caucasian Renal Transplant Patients Are Comparable
  The Journal of Clinical Pharmacology, 2000
• Clinical Pharmacokinetics of Mycophenolate Mofetil
  Clinical Pharmacokinetics, 1998
• Effects of food and antacid on the pharmacokinetics of single doses of mycophenolate mofetil in rheumatoid arthritis patients
  British Journal of Clinical Pharmacology, 1996
• Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous Administration
  The Journal of Clinical Pharmacology, 1996